Rapid desensitization of somatodendritic 5‐HT1Areceptors by chronic administration of the high‐efficacy 5‐HT1Aagonist, F13714: a microdialysis study in the rat
- 1 September 2006
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 149 (2) , 170-178
- https://doi.org/10.1038/sj.bjp.0706859
Abstract
Background and purpose: Desensitization of somatodendritic 5‐HT1Areceptors is involved in the mechanism of action of several antidepressants, but the rapidity of this effect and the amount of agonist stimulation needed are unclear. We evaluated the capacity of the high‐efficacy 5‐HT1Aagonist, F13714 (3‐chloro‐4‐fluorophenyl‐(4‐fluoro‐4‐{[(5‐methyl‐6‐methylamino‐pyridin‐2‐ylmethyl)‐amino]‐methyl}‐piperidin‐1‐yl‐methanone) and of the partial agonist, flesinoxan, to desensitize somatodendritic 5‐HT1Areceptors involved in the control of 5‐HT release.Experimental approach: Intracerebral microdialysis in the hippocampus of freely moving rats was used to examine the acute and chronic effects of the two compounds (administered by osmotic pumps for 3, 7 or 14 days) on extracellular 5‐HT levels, measured by HPLC with electrochemical detection.Key results: When given acutely, F13714, flesinoxan and the low‐efficacy 5‐HT1Aagonist, buspirone, dose‐dependently decreased extracellular 5‐HT concentrations (ED50values: 0.04, 0.77 and 5.6 mg kg−1, respectively). The selective 5‐HT1Aantagonist WAY100635 inhibited the effects of the three compounds. F13714 (2.5 mg kg−1per day for 3, 7 or 14 days and 0.63 mg kg−1for 7 days) significantly attenuated the inhibition of 5‐HT release induced by buspirone (10 mg kg−1). In contrast, flesinoxan (10 mg kg−1per day) failed to alter the response to buspirone at any of the treatment durations.Conclusions and implications:Rat somatodendritic 5‐HT1Areceptors controlling hippocampal 5‐HT release were rapidly desensitized by chronic activation with a high‐efficacy 5‐HT1Aagonist, but not by chronic activation with a partial agonist. Thus, rapid 5‐HT1Aautoreceptor desensitization by high‐efficacy agonists may accelerate the onset of the therapeutic effects of antidepressants.British Journal of Pharmacology(2006)149, 170–178. doi:10.1038/sj.bjp.0706859Keywords
This publication has 95 references indexed in Scilit:
- Allelic diversity of metallothionein in Orchesella cincta (L.): traces of natural selection by environmental pollutionHeredity, 2007
- Cloning of crucian carp (Carassius cuvieri) metallothionein-II gene and characterization of its gene promoter regionBiochemical and Biophysical Research Communications, 2006
- Application of Phylogenetic Networks in Evolutionary StudiesMolecular Biology and Evolution, 2005
- Metallothionein mRNA Expression and Cadmium Tolerance in Metal-stressed and Reference Populations of the Springtail Orchesella cinctaEcotoxicology, 2005
- Functional Evolution of a cis-Regulatory ModulePLoS Biology, 2005
- GenePalette: a universal software tool for genome sequence visualization and analysisDevelopmental Biology, 2004
- BuspironeCNS Drugs, 1997
- Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levelsGeneral Pharmacology: The Vascular System, 1996
- Response of Drosophila metallothionein promoters to metallic, heat shock and oxidative stressesFEBS Letters, 1996
- Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: Raphé control of somatodendritic and terminal 5-HT releaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996